Cargando…

Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study

OBJECTIVE: To investigate the survival and independent prognostic factors for single large hepatocellular carcinoma (SLHCC) after surgical resection. METHODS: Patients with SLHCC who underwent radical resection from January 2013 to December 2017 were retrospectively analyzed. The Kaplan-Meier method...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jian, Li, Li, Liu, Fu-Chen, Tan, Bi-Bo, Yang, Yun, Jiang, Bei-Ge, Pan, Ze-Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086221/
https://www.ncbi.nlm.nih.gov/pubmed/37056420
http://dx.doi.org/10.2147/JHC.S404895
_version_ 1785022102232891392
author Huang, Jian
Li, Li
Liu, Fu-Chen
Tan, Bi-Bo
Yang, Yun
Jiang, Bei-Ge
Pan, Ze-Ya
author_facet Huang, Jian
Li, Li
Liu, Fu-Chen
Tan, Bi-Bo
Yang, Yun
Jiang, Bei-Ge
Pan, Ze-Ya
author_sort Huang, Jian
collection PubMed
description OBJECTIVE: To investigate the survival and independent prognostic factors for single large hepatocellular carcinoma (SLHCC) after surgical resection. METHODS: Patients with SLHCC who underwent radical resection from January 2013 to December 2017 were retrospectively analyzed. The Kaplan-Meier method was used to analyze the overall survival (OS) rate and recurrence-free survival (RFS) rates. Cox forward stepwise regression was performed to analyze the independent prognostic factors. RESULTS: A total of 485 cases were included. The average age was 51.2±11.2 years, 88.9% had a history of hepatitis B virus infection, and most patients had normal liver function. The average tumor diameter was 8.8±3.0 cm. The 1-, 3-, and 5-year OS and RFS rates were 76.8%, 56.7%, and 45.7%, and 61.0%, 46.2%, and 34.7%, respectively. Multivariate analysis showed that liver cirrhosis (HR=1.456, P=0.004), total bilirubin (TB) ≥17.1 μmol/L (HR=1.437, P=0.011), glutamyl transferase (GGT) >60 U/L (HR=1.438, P=0.020), lactate dehydrogenase (LDH) >225 U/L (HR=1.442, P=0.007), blood loss ≥400 mL (HR=1.339, P=0.027), microvascular invasion (MVI) (HR=1.492, P=0.004), satellite lesions (HR=1.859, P<0.0001) and Edmondson-Steiner grade III+IV (HR=1.740, P=0.018) were independent risk factors for reduced OS in SLHCC patients. Sex (HR=1.763, P=0.003), liver cirrhosis (HR=1.382, P=0.007), GGT >60 U/L (HR=1.512, P=0.003), LDH >225 U/L (HR=1.480, P=0.002), MVI (HR=1.545, P=0.001), and satellite lesions (HR=1.564, P=0.001) were independent risk factors for reduced RFS. OS and RFS nomograms were constructed using risk factors with C-index values of 0.692 (95% CI: 0.659–0.724) and 0.659 (95% CI: 0.623–0.693), respectively. The Hosmer-Leme test demonstrated the good fit of both nomograms. CONCLUSION: Surgical resection is the standard and effective treatment for SLHCC patients. Sex, liver cirrhosis, TB≥17.1 μmol/L, GGT>60 U/L, LDH>225 U/L, blood loss≥400 mL, MVI, Edmondson-Steiner grade III+IV, and satellite lesions were found to be independent prognostic factors in SLHCC patients following radical resection. The OS and RFS nomograms accurately predicted the prognosis of SLHCC patients.
format Online
Article
Text
id pubmed-10086221
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100862212023-04-12 Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study Huang, Jian Li, Li Liu, Fu-Chen Tan, Bi-Bo Yang, Yun Jiang, Bei-Ge Pan, Ze-Ya J Hepatocell Carcinoma Original Research OBJECTIVE: To investigate the survival and independent prognostic factors for single large hepatocellular carcinoma (SLHCC) after surgical resection. METHODS: Patients with SLHCC who underwent radical resection from January 2013 to December 2017 were retrospectively analyzed. The Kaplan-Meier method was used to analyze the overall survival (OS) rate and recurrence-free survival (RFS) rates. Cox forward stepwise regression was performed to analyze the independent prognostic factors. RESULTS: A total of 485 cases were included. The average age was 51.2±11.2 years, 88.9% had a history of hepatitis B virus infection, and most patients had normal liver function. The average tumor diameter was 8.8±3.0 cm. The 1-, 3-, and 5-year OS and RFS rates were 76.8%, 56.7%, and 45.7%, and 61.0%, 46.2%, and 34.7%, respectively. Multivariate analysis showed that liver cirrhosis (HR=1.456, P=0.004), total bilirubin (TB) ≥17.1 μmol/L (HR=1.437, P=0.011), glutamyl transferase (GGT) >60 U/L (HR=1.438, P=0.020), lactate dehydrogenase (LDH) >225 U/L (HR=1.442, P=0.007), blood loss ≥400 mL (HR=1.339, P=0.027), microvascular invasion (MVI) (HR=1.492, P=0.004), satellite lesions (HR=1.859, P<0.0001) and Edmondson-Steiner grade III+IV (HR=1.740, P=0.018) were independent risk factors for reduced OS in SLHCC patients. Sex (HR=1.763, P=0.003), liver cirrhosis (HR=1.382, P=0.007), GGT >60 U/L (HR=1.512, P=0.003), LDH >225 U/L (HR=1.480, P=0.002), MVI (HR=1.545, P=0.001), and satellite lesions (HR=1.564, P=0.001) were independent risk factors for reduced RFS. OS and RFS nomograms were constructed using risk factors with C-index values of 0.692 (95% CI: 0.659–0.724) and 0.659 (95% CI: 0.623–0.693), respectively. The Hosmer-Leme test demonstrated the good fit of both nomograms. CONCLUSION: Surgical resection is the standard and effective treatment for SLHCC patients. Sex, liver cirrhosis, TB≥17.1 μmol/L, GGT>60 U/L, LDH>225 U/L, blood loss≥400 mL, MVI, Edmondson-Steiner grade III+IV, and satellite lesions were found to be independent prognostic factors in SLHCC patients following radical resection. The OS and RFS nomograms accurately predicted the prognosis of SLHCC patients. Dove 2023-04-06 /pmc/articles/PMC10086221/ /pubmed/37056420 http://dx.doi.org/10.2147/JHC.S404895 Text en © 2023 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Huang, Jian
Li, Li
Liu, Fu-Chen
Tan, Bi-Bo
Yang, Yun
Jiang, Bei-Ge
Pan, Ze-Ya
Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
title Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
title_full Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
title_fullStr Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
title_full_unstemmed Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
title_short Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
title_sort prognostic analysis of single large hepatocellular carcinoma following radical resection: a single-center study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086221/
https://www.ncbi.nlm.nih.gov/pubmed/37056420
http://dx.doi.org/10.2147/JHC.S404895
work_keys_str_mv AT huangjian prognosticanalysisofsinglelargehepatocellularcarcinomafollowingradicalresectionasinglecenterstudy
AT lili prognosticanalysisofsinglelargehepatocellularcarcinomafollowingradicalresectionasinglecenterstudy
AT liufuchen prognosticanalysisofsinglelargehepatocellularcarcinomafollowingradicalresectionasinglecenterstudy
AT tanbibo prognosticanalysisofsinglelargehepatocellularcarcinomafollowingradicalresectionasinglecenterstudy
AT yangyun prognosticanalysisofsinglelargehepatocellularcarcinomafollowingradicalresectionasinglecenterstudy
AT jiangbeige prognosticanalysisofsinglelargehepatocellularcarcinomafollowingradicalresectionasinglecenterstudy
AT panzeya prognosticanalysisofsinglelargehepatocellularcarcinomafollowingradicalresectionasinglecenterstudy